The Innovation Pipeline features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.
2020 Innovation Pipeline Participants:
BittyLab LLC: MedTech start-up that designs and develops products for infants with GER, GERD, and complications due to GERD.
Priska Diaz, MS, Founder & CEO
BUPeriod: Building a D2C Smart Menstrual Health Pad, that identifies menstrual health risks, via sensor technologies, associated with heavy menstrual flow and potential Iron Deficiency Anemia (IDA).
Vanessa Siverls, Founder & CEO, BUPeriod
CardiaTouch Control Systems: Developed and patented Haptic (tactile and force) Feedback systems for cardiac and vascular interventions that enable operators to palpate blood flow, catheter: tissue contact force, intra-cardiac pressure, and other biophysical signals in real time for the first time.
Stuart Schecter,MD, FACC, FASE. Founder, Owner & CTO, CardiaTouch Control, Director of the Mount Sinai Health Network Cardiac Device Remote Monitoring System, and an Associate Professor of Cardiology, Mount Sinai Medical Center, NY.
Chemeleon: Chemeleon has created a novel platform technology for rapid, accurate and affordable diagnostics that are capable of detecting a broad range of analytes including drugs, proteins and viruses.
Brendan Walker, CEO
Deka Biosciences: Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases.
Pavel Khrimian, Co-Founder & CBO
Face2Face Health: Face2Face Health is a transformative digital health platform, providing parents with a
single, end-to-end solution to help optimize healthcare for their kids.
Ami Shah, MD, FACP, FAARM, Founder & CEO
Iocure: Developing an inexpensive way of delivering and formulating an existing molecule for the treatment of respiratory pathogens such as COVID-19.
Daniel Farb, MD, CEO
KannaLife: Developing a pipeline of next generation cannabinoid therapeutics for the treatment of neurodegeneration, oxidative stress and neuropathic pain related diseases.
Dean Petkanas, CEO, Kannalife, Inc.
Lahara Bio: Developing a novel, non-invasive, non-chemical approach to enhance cell-based biomanufacturing outcomes will use cell-specific mechanical signals in the form of LIV to stimulate proliferation in human T-cells.
Ete Chan, PhD, CTO
Laronix Pty. Ltd. Larynx is developing a smart, wearable (non-invasive), artificial voice box for larynx amputees. Using a combination of AI and sensors on the neck, Laronix technology creates an exceptionally high quality natural sounding voice for these people
Dr. Farzaneh Ahmadi, Founder & CEO
Lipophagy Therapeutics: Developing a proprietary screening platform to discover lipophagy modulators as a new class of medicines for patients with a metabolically distinct cancer as a leading indication.
Prakrit V. Jena, Ph.D. Co-Founder and CEO Lipophagy Therapeutics. Fellow, ELabNYC.
MaMome, Inc.: MaMome is an early-stage biotech company that optimize nutrition plans that strengthen the microbiome of the mother and child utilizing maternal metagenomic data to optimize nutrition plans that strengthen the microbiome of the mother and child.
Nini Fan, Founder & CEO, MaMome, Inc.
MicroRid Technologies, Inc: Advancing a new class of antifungal agents with a fungal-specific mechanism of action (First-in-Class) by targeting sphingolipid metabolism specific to fungi.
Brian McCarthy, PhD. Co-Founder, MicroRid Technologies, Inc. CEO Adera BioLabs, BioEntrepreneur-in-Residence, Center for Biotechnology.
Multistep Platform for Single-Cell and Spatial Genomics: Developing a technology that addresses current limitations with single cell genomics (complex actuation, low capacity, low capture yield) and spatial genomics (loss of resolution, limited number of reads per barcode). Dr. Brouzes’ platform’s flexibility also enables the development of unique digital bacterial assays.
Eric Brouzes, PhD, Stony Brook University Department of Biomedical Engineering
Orchid Imaging: Commercializing 3D scanning technology and developing a system thatcan be used by dermatologists for fast, accurate and automated detection of melanoma.
Rong Zhao,PhD. CEO, Orchid Imagingecast Inc; Director of Software Systems Division at CEWIT, Faculty Member of Department of Computer Science and Adjunct Faculty of Department of Technology & Society at Stony Brook University.
PolyNova Cardiovascular: Developing a safe and effective polymeric transcatheter heart valve technology for prosthetic heart valves for over-the-wire procedures (TAVR).
Danny Bluestein, PhD. CSO, PolyNova Cardiovascular. Professor – Biomedical Engineering, Stony Brook University.
SynchroPET: SynchroPET has a unique new was to build PET (Positron Emission Tomography) devices which enables them to build them much smaller and MRI compatible to retrofit or be used as an add on device to existing PET Scanners and MRI’s to make them more quantitative and accurate for the research, diagnosis and treatment of a myriad of diseases like cancer, alzheimer’s, cardiology etc.
Marc Alessi, CEO
TAP Diagnostics: TAP Diagnostics aims to deliver a fast and repeatable way for everyone, everywhere to test for COVID-19 infection at the convenience of your home. Based on lateral flow assay (LFA) design, just like pregnancy tests, TAP Tests are poised to deliver reliable results in just 15 minutes with a simple saliva sample.
Jin Kim Montclare, PhD, Founder
Viral Forecast Inc: Personal smart phone-integrated virus sensors and mobile app for rapid and accurate saliva screening and option to share results with businesses and entertainment venues before entering common space.
Matthew Jacobs, DO. Founder & CEO, Viral Forecast Inc; Chief Resident, Psychiatry – Stony Brook Medicine